In many cases, a missed or slightly delayed GLP-1 dose is manageable, but the right approach depends on your specific medication and timing
Patients experiencing severe abdominal pain, persistent vomiting, signs of infection, or allergic reactions should seek urgent medical attention
demonstrated that the GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant Apoe/Irs2+/ mice by promoting macrophage polarization towards an anti-inflammatory M2 phenotype, which was associated with enhanced plaque stability (i.e., thicker fibrous caps, fewer necrotic cores, and decreased inflammatory infiltrates)
Thats a user population that includes not only weight lifters and bodybuilders but also people at risk for: Sarcopenia The worldwide prevalence of sarcopenia, or age-related muscle loss, is 10-16%, so its far from uncommon.31 And because people begin to lose 3-8% of their existing muscle mass with every proceeding decade of adult life, it behooves you to take active measures to preserve the lean mass you have.32 Otherwise, you may find yourself struggling with physical weakness and decreased physiological function as you grow older.33 Resistance training can mitigate the risk, and a growth hormone secretagogue peptide can support your resistance training
However, any consideration of these peptides must come with medical oversight, safe sourcing, and clear understanding that they are still research products